Plasma Metabolomic Profiles of Glycemic Index, Glycemic Load, and Carbohydrate Quality Index in the PREDIMED Study.
PREDIMED
carbohydrate quality index
glycemic index
glycemic load
metabolomics
Journal
The Journal of nutrition
ISSN: 1541-6100
Titre abrégé: J Nutr
Pays: United States
ID NLM: 0404243
Informations de publication
Date de publication:
04 01 2021
04 01 2021
Historique:
received:
28
08
2020
revised:
10
09
2020
accepted:
07
10
2020
pubmed:
10
12
2020
medline:
7
4
2021
entrez:
9
12
2020
Statut:
ppublish
Résumé
The quality of carbohydrate consumed, assessed by the glycemic index (GI), glycemic load (GL), or carbohydrate quality index (CQI), affects the postprandial glycemic and insulinemic responses, which have been implicated in the etiology of several chronic diseases. However, it is unclear whether plasma metabolites involved in different biological pathways could provide functional insights into the role of carbohydrate quality indices in health. We aimed to identify plasma metabolomic profiles associated with dietary GI, GL, and CQI. The present study is a cross-sectional analysis of 1833 participants with overweight/obesity (mean age = 67 y) from 2 case-cohort studies nested within the PREDIMED (Prevención con Dieta Mediterránea) trial. Data extracted from validated FFQs were used to estimate the GI, GL, and CQI. Plasma concentrations of 385 metabolites were profiled with LC coupled to MS and associations of these metabolites with those indices were assessed with elastic net regression analyses. A total of 58, 18, and 57 metabolites were selected for GI, GL, and CQI, respectively. Choline, cotinine, γ-butyrobetaine, and 36:3 phosphatidylserine plasmalogen were positively associated with GI and GL, whereas they were negatively associated with CQI. Fructose-glucose-galactose was negatively and positively associated with GI/GL and CQI, respectively. Consistent associations of 21 metabolites with both GI and CQI were found but in opposite directions. Negative associations of kynurenic acid, 22:1 sphingomyelin, and 38:6 phosphatidylethanolamine, as well as positive associations of 32:1 phosphatidylcholine with GI and GL were also observed. Pearson correlation coefficients between GI, GL, and CQI and the metabolomic profiles were 0.30, 0.22, and 0.27, respectively. The GI, GL, and CQI were associated with specific metabolomic profiles in a Mediterranean population at high cardiovascular disease risk. Our findings may help in understanding the role of dietary carbohydrate indices in the development of cardiometabolic disorders. This trial was registered at isrctn.com as ISRCTN35739639.
Sections du résumé
BACKGROUND
The quality of carbohydrate consumed, assessed by the glycemic index (GI), glycemic load (GL), or carbohydrate quality index (CQI), affects the postprandial glycemic and insulinemic responses, which have been implicated in the etiology of several chronic diseases. However, it is unclear whether plasma metabolites involved in different biological pathways could provide functional insights into the role of carbohydrate quality indices in health.
OBJECTIVES
We aimed to identify plasma metabolomic profiles associated with dietary GI, GL, and CQI.
METHODS
The present study is a cross-sectional analysis of 1833 participants with overweight/obesity (mean age = 67 y) from 2 case-cohort studies nested within the PREDIMED (Prevención con Dieta Mediterránea) trial. Data extracted from validated FFQs were used to estimate the GI, GL, and CQI. Plasma concentrations of 385 metabolites were profiled with LC coupled to MS and associations of these metabolites with those indices were assessed with elastic net regression analyses.
RESULTS
A total of 58, 18, and 57 metabolites were selected for GI, GL, and CQI, respectively. Choline, cotinine, γ-butyrobetaine, and 36:3 phosphatidylserine plasmalogen were positively associated with GI and GL, whereas they were negatively associated with CQI. Fructose-glucose-galactose was negatively and positively associated with GI/GL and CQI, respectively. Consistent associations of 21 metabolites with both GI and CQI were found but in opposite directions. Negative associations of kynurenic acid, 22:1 sphingomyelin, and 38:6 phosphatidylethanolamine, as well as positive associations of 32:1 phosphatidylcholine with GI and GL were also observed. Pearson correlation coefficients between GI, GL, and CQI and the metabolomic profiles were 0.30, 0.22, and 0.27, respectively.
CONCLUSIONS
The GI, GL, and CQI were associated with specific metabolomic profiles in a Mediterranean population at high cardiovascular disease risk. Our findings may help in understanding the role of dietary carbohydrate indices in the development of cardiometabolic disorders. This trial was registered at isrctn.com as ISRCTN35739639.
Identifiants
pubmed: 33296468
pii: S0022-3166(22)00027-X
doi: 10.1093/jn/nxaa345
pmc: PMC7779218
doi:
Substances chimiques
Biomarkers
0
Dietary Carbohydrates
0
Banques de données
ISRCTN
['ISRCTN35739639']
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
50-58Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK040561
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK102896
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL118264
Pays : United States
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the American Society for Nutrition.
Références
Br J Nutr. 2010 Jun;103(12):1808-16
pubmed: 20102675
Diabetes Care. 2008 Dec;31(12):2281-3
pubmed: 18835944
Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):2041-8
pubmed: 23723367
Am J Clin Nutr. 2019 Mar 1;109(3):626-634
pubmed: 30796776
Food Funct. 2015 Sep;6(9):2949-56
pubmed: 26165375
PLoS One. 2012;7(5):e37883
pubmed: 22649561
Nat Med. 2015 Jun;21(6):638-46
pubmed: 26005855
Am J Epidemiol. 1994 Jun 15;139(12):1197-209
pubmed: 8209878
Proc Natl Acad Sci U S A. 2017 May 30;114(22):E4472-E4481
pubmed: 28507131
Nutrients. 2019 Jun 25;11(6):
pubmed: 31242690
J Am Heart Assoc. 2018 Apr 12;7(8):
pubmed: 29650710
J Hum Nutr Diet. 2018 Oct;31(5):587-596
pubmed: 29744944
J Stat Softw. 2010;33(1):1-22
pubmed: 20808728
Mol Nutr Food Res. 2019 Jan;63(1):e1700975
pubmed: 29603657
Nutrients. 2019 Jun 05;11(6):
pubmed: 31195724
Front Pharmacol. 2012 Oct 10;3:173
pubmed: 23087643
Eur J Clin Nutr. 2002 Nov;56(11):1049-71
pubmed: 12428171
Mol Nutr Food Res. 2010 Jul;54(7):897-908
pubmed: 20013882
Diabetes. 2013 Feb;62(2):639-48
pubmed: 23043162
Eur J Clin Nutr. 2015 Mar;69(3):297-302
pubmed: 25226822
Sci Rep. 2017 Oct 20;7(1):13670
pubmed: 29057986
Circulation. 2017 May 23;135(21):2028-2040
pubmed: 28280233
Am J Clin Nutr. 2016 Jun;103(6):1408-16
pubmed: 27099249
Int J Epidemiol. 2012 Apr;41(2):377-85
pubmed: 21172932
J Clin Invest. 2017 Dec 1;127(12):4394-4402
pubmed: 29083323
J Nutr. 2008 May;138(5):914-20
pubmed: 18424601
Am J Clin Nutr. 2019 Oct 1;110(4):984-992
pubmed: 31432072
Am J Clin Nutr. 2008 Mar;87(3):627-37
pubmed: 18326601
N Engl J Med. 2018 Jun 21;378(25):e34
pubmed: 29897866
Nutr Metab Cardiovasc Dis. 2016 Nov;26(11):1048-1056
pubmed: 27524801
Am J Clin Nutr. 2018 Jul 1;108(1):163-173
pubmed: 29982310
Cell Metab. 2014 Nov 4;20(5):799-812
pubmed: 25440057
Br J Nutr. 2014 Jun 14;111(11):2000-9
pubmed: 24666554
Int J Mol Sci. 2019 Jan 15;20(2):
pubmed: 30650577
J Am Geriatr Soc. 2015 Oct;63(10):1991-2000
pubmed: 26480969
Am J Clin Nutr. 1981 Mar;34(3):362-6
pubmed: 6259925
Am J Clin Nutr. 2017 Mar;105(3):547-554
pubmed: 28077380
J Nutr. 2003 May;133(5):1302-7
pubmed: 12730414
Am J Clin Nutr. 2004 Aug;80(2):243-4
pubmed: 15277141
JAMA. 1997 Feb 12;277(6):472-7
pubmed: 9020271
Obes Rev. 2012 Oct;13(10):923-84
pubmed: 22780564
J Am Heart Assoc. 2017 Oct 28;6(11):
pubmed: 29080862
Nutrients. 2018 Nov 14;10(11):
pubmed: 30441841
Am J Med. 2010 Oct;123(10):957-61
pubmed: 20920699
Eur Heart J. 2006 May;27(10):1174-81
pubmed: 16611671
Lipids Health Dis. 2018 Jan 29;17(1):18
pubmed: 29375034
Hypertension. 2003 Jun;41(6):1183-90
pubmed: 12707287